Skip to main content
. 2021 May 26;11:11001. doi: 10.1038/s41598-021-90215-5

Table 6.

Perioperative and short-term outcomes of patients with nCRT.

Before propensity score matching After propensity score matching
Open
(n = 71)
MIS
(n = 42)
p Open
(n = 42)
MIS
(n = 42)
p
MIS approach
Laparoscopic surgery 29 (69.0) 29 (69.0)
Robotic surgery 13 (31.0) 13 (31.0)
Operation time (minutes) 184 ± 51 249 ± 83  < 0.001 194 ± 67 249 ± 83  < 0.001
Stoma formation, n (%) 53 (74.6) 40 (95.2) 0.006 32 (76.2) 40 (95.2) 0.013
Transfusion, n (%) 5 (7.0) 1 (2.4) 0.409 5 (11.9) 1 (2.4) 0.202
Open conversion, n (%) 1 (2.4) 1 (2.4)
Readmission, n (%) 5 (7.0) 3 (7.1) 1.000 1 (2.4) 3 (7.1) 0.616
Postoperative morbidity 19 (26.8) 8 (19.0) 0.374 9 (21.4) 8 (19.0) 0.786
Surgical site infection 6 (8.5) 1 (2.4) 0.255 2 (4.8) 1 (2.4) 0.557
Postoperative ileus 9 (12.7) 2 (4.8) 0.207 3 (7.1) 2 (4.8) 0.645
Anastomotic site leakage 2 (2.8) 1 (2.4) 1.000 1 (2.4) 1 (2.4) 1.000
Rectovaginal fistula 2 (2.8) 0 (0.0) 0.529 1 (2.4) 0 (0.0) 0.314
Intra-abdominal abscess 0 (0.0) 0 (0.0) 1.000 0 (0.0) 0 (0.0) 1.000
Urinary retention 2 (2.8) 3 (7.1) 0.359 1 (2.4) 3 (7.1) 0.616
Postoperative mortality (< POD30) 0 (0.0) 0 (0.0) 1.000 0 (0.0) 0 (0.0) 1.000
Length of stay (days) 11.4 ± 4.6 9.0 ± 3.2 0.005 11.2 ± 4.5 9.0 ± 3.2 0.012
Time to diet (days) 2.0 ± 0.2 2.1 ± 0.6 0.235 2.4 ± 0.7 2.1 ± 0.6 0.099
Flatus passage (days) 2.5 ± 2.1 1.6 ± 0.9 0.651 3.0 ± 0.6 1.6 ± 0.9  < 0.001

nCRT neoadjuvant chemoradiotherapy, MIS minimally invasive surgery.